Decreased Blood Pressure Response in Mice Deficient of the Alpha1b-adrenergic Receptor

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1997 Oct 23

PMID 9326654

Citations 63

Authors

A Cavalli

A L Lattion

E Hummler

M Nenniger

T Pedrazzini

J F Aubert

M C Michel

M Yang

G Lembo

C Vecchione

M Mostardini

A Schmidt

F Beermann

S Cotecchia

Affiliations

Soon will be listed here.

Abstract

To investigate the functional role of different alpha1-adrenergic receptor (alpha1-AR) subtypes in vivo, we have applied a gene targeting approach to create a mouse model lacking the alpha1b-AR (alpha1b-/-). Reverse transcription-PCR and ligand binding studies were combined to elucidate the expression of the alpha1-AR subtypes in various tissues of alpha1b +/+ and -/- mice. Total alpha1-AR sites were decreased by 98% in liver, 74% in heart, and 42% in cerebral cortex of the alpha1b -/- as compared with +/+ mice. Because of the large decrease of alpha1-AR in the heart and the loss of the alpha1b-AR mRNA in the aorta of the alpha1b-/- mice, the in vivo blood pressure and in vitro aorta contractile responses to alpha1-agonists were investigated in alpha1b +/+ and -/- mice. Our findings provide strong evidence that the alpha1b-AR is a mediator of the blood pressure and the aorta contractile responses induced by alpha1 agonists. This was demonstrated by the finding that the mean arterial blood pressure response to phenylephrine was decreased by 45% in alpha1b -/- as compared with +/+ mice. In addition, phenylephrine-induced contractions of aortic rings also were decreased by 25% in alpha1b-/- mice. The alpha1b-AR knockout mouse model provides a potentially useful tool to elucidate the functional specificity of different alpha1-AR subtypes, to better understand the effects of adrenergic drugs, and to investigate the multiple mechanisms involved in the control of blood pressure.

Citing Articles

Biphasic effects of single-dose intravenous injection of uridine adenosine tetraphosphate on blood pressure in mice.

Ma Y, An C, Wang X, Gan L, Li L, Li K Eur J Med Res. 2024; 29(1):471.

PMID: 39342387 PMC: 11438126. DOI: 10.1186/s40001-024-02038-5.

Liver adrenoceptor alpha-1b plays a key role in energy and glucose homeostasis in female mice.

Silva A, Mouchiroud M, Lavoie O, Beji S, Elmquist J, Caron A Am J Physiol Endocrinol Metab. 2024; 327(5):E626-E635.

PMID: 39259165 PMC: 11559639. DOI: 10.1152/ajpendo.00153.2024.

Artificial light at night affects the daily profile of pulse pressure and protein expression in the thoracic aorta of rats.

Sutovska H, Obermajer V, Zeman M, Molcan L Hypertens Res. 2024; 47(7):1897-1907.

PMID: 38664509 PMC: 11224016. DOI: 10.1038/s41440-024-01685-9.

Adrenergic receptor system as a pharmacological target in the treatment of epilepsy (Review).

Ozdemir E Med Int (Lond). 2024; 4(2):20.

PMID: 38476984 PMC: 10928664. DOI: 10.3892/mi.2024.144.

Structural basis of agonist specificity of α-adrenergic receptor.

Su M, Wang J, Xiang G, Do H, Levitz J, Miao Y Nat Commun. 2023; 14(1):4819.

PMID: 37563160 PMC: 10415349. DOI: 10.1038/s41467-023-40524-2.

References

Schwinn D, Lomasney J, Lorenz W, Szklut P, Fremeau Jr R, Yang-Feng T . Molecular cloning and expression of the cDNA for a novel alpha 1-adrenergic receptor subtype. J Biol Chem. 1990; 265(14):8183-9. View

Shubeita H, McDonough P, Harris A, Knowlton K, Glembotski C, Brown J . Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly, and cardiac gene expression in ventricular myocytes. A paracrine mechanism for myocardial cell hypertrophy. J Biol Chem. 1990; 265(33):20555-62. View

Lomasney J, Cotecchia S, Lorenz W, Leung W, Schwinn D, Yang-Feng T . Molecular cloning and expression of the cDNA for the alpha 1A-adrenergic receptor. The gene for which is located on human chromosome 5. J Biol Chem. 1991; 266(10):6365-9. View

Perez D, Piascik M, Graham R . Solution-phase library screening for the identification of rare clones: isolation of an alpha 1D-adrenergic receptor cDNA. Mol Pharmacol. 1991; 40(6):876-83. View

Ramarao C, Denker J, Perez D, Gaivin R, Riek R, Graham R . Genomic organization and expression of the human alpha 1B-adrenergic receptor. J Biol Chem. 1992; 267(30):21936-45. View

Glembotski C, Irons C, Krown K, Murray S, Sprenkle A, Sei C . Myocardial alpha-thrombin receptor activation induces hypertrophy and increases atrial natriuretic factor gene expression. J Biol Chem. 1993; 268(27):20646-52. View

Michel M, Buscher R, Kerker J, Kraneis H, Erdbrugger W, Brodde O . Alpha 1-adrenoceptor subtype affinities of drugs for the treatment of prostatic hypertrophy. Evidence for heterogeneity of chloroethylclonidine-resistant rat renal alpha 1-adrenoceptor. Naunyn Schmiedebergs Arch Pharmacol. 1993; 348(4):385-95. DOI: 10.1007/BF00171338. View

Weinberg D, Trivedi P, Tan C, Mitra S, Borkowski D, Strader C . Cloning, expression and characterization of human alpha adrenergic receptors alpha 1a, alpha 1b and alpha 1c. Biochem Biophys Res Commun. 1994; 201(3):1296-304. DOI: 10.1006/bbrc.1994.1845. View

Minneman K, Esbenshade T . Alpha 1-adrenergic receptor subtypes. Annu Rev Pharmacol Toxicol. 1994; 34:117-33. DOI: 10.1146/annurev.pa.34.040194.001001. View

10.

Milano C, Dolber P, Rockman H, Bond R, Venable M, Allen L . Myocardial expression of a constitutively active alpha 1B-adrenergic receptor in transgenic mice induces cardiac hypertrophy. Proc Natl Acad Sci U S A. 1994; 91(21):10109-13. PMC: 44967. DOI: 10.1073/pnas.91.21.10109. View

11.

Link R, Stevens M, Kulatunga M, Scheinin M, Barsh G, Kobilka B . Targeted inactivation of the gene encoding the mouse alpha 2c-adrenoceptor homolog. Mol Pharmacol. 1995; 48(1):48-55. View

12.

Lembo G, Iaccarino G, Vecchione C, Rendina V, Trimarco B . Insulin modulation of vascular reactivity is already impaired in prehypertensive spontaneously hypertensive rats. Hypertension. 1995; 26(2):290-3. DOI: 10.1161/01.hyp.26.2.290. View

13.

Michel M, Kenny B, Schwinn D . Classification of alpha 1-adrenoceptor subtypes. Naunyn Schmiedebergs Arch Pharmacol. 1995; 352(1):1-10. DOI: 10.1007/BF00169183. View

14.

Alonso-Llamazares A, Zamanillo D, Casanova E, Ovalle S, Calvo P, Chinchetru M . Molecular cloning of alpha 1d-adrenergic receptor and tissue distribution of three alpha 1-adrenergic receptor subtypes in mouse. J Neurochem. 1995; 65(6):2387-92. DOI: 10.1046/j.1471-4159.1995.65062387.x. View

15.

Kenny B, Chalmers D, Philpott P, Naylor A . Characterization of an alpha 1D-adrenoceptor mediating the contractile response of rat aorta to noradrenaline. Br J Pharmacol. 1995; 115(6):981-6. PMC: 1908994. DOI: 10.1111/j.1476-5381.1995.tb15907.x. View

16.

Susulic V, Frederich R, Lawitts J, Tozzo E, Kahn B, Harper M . Targeted disruption of the beta 3-adrenergic receptor gene. J Biol Chem. 1995; 270(49):29483-92. DOI: 10.1074/jbc.270.49.29483. View

17.

Piascik M, Guarino R, Smith M, Soltis E, Saussy Jr D, Perez D . The specific contribution of the novel alpha-1D adrenoceptor to the contraction of vascular smooth muscle. J Pharmacol Exp Ther. 1995; 275(3):1583-9. View

18.

Hummler E, Barker P, GATZY J, Beermann F, Verdumo C, Schmidt A . Early death due to defective neonatal lung liquid clearance in alpha-ENaC-deficient mice. Nat Genet. 1996; 12(3):325-8. DOI: 10.1038/ng0396-325. View

19.

Graham R, Perez D, Hwa J, Piascik M . alpha 1-adrenergic receptor subtypes. Molecular structure, function, and signaling. Circ Res. 1996; 78(5):737-49. DOI: 10.1161/01.res.78.5.737. View

20.

Rohrer D, Desai K, Jasper J, Stevens M, Regula Jr D, Barsh G . Targeted disruption of the mouse beta1-adrenergic receptor gene: developmental and cardiovascular effects. Proc Natl Acad Sci U S A. 1996; 93(14):7375-80. PMC: 38992. DOI: 10.1073/pnas.93.14.7375. View